Psoriatic Arthritis

Assessing the Accuracy of Questionnaire-Based Screening Tools for Detection of Psoriatic Arthritis

Assessing the Accuracy of Questionnaire-Based Screening Tools for Detection of Psoriatic Arthritis

By

Researchers reviewed the accuracy and characteristics of questionnaire-based PsA screening tools.

Filgotinib Effective for Treatment of Active Psoriatic Arthritis

Filgotinib Effective for Treatment of Active Psoriatic Arthritis

By

Data show that filgotinib is effective for the treatment of active psoriatic arthritis.

Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

By

Data show an increased prevalence of psoriasis in patients with gout compared with patients without gout.

Influenza Vaccination Low in Rheumatoid Arthritis, Psoriatic Arthritis

Influenza Vaccination Low in Rheumatoid Arthritis, Psoriatic Arthritis

By

Patients with rheumatoid arthritis or psoriatic arthritis have a low influenza vaccination rate, despite the recommendation from the CDC to be vaccinated annually.

Sustained Joint and Skin Improvement Found With Bimekizumab in Psoriatic Arthritis

Sustained Joint and Skin Improvement Found With Bimekizumab in Psoriatic Arthritis

Christopher T. Ritchlin, MD, MPH, discusses updated bimekizumab data from the BE-ACTIVE trial.

Statins May Decrease C-Reactive Protein Levels in Psoriatic Arthritis

Statins May Decrease C-Reactive Protein Levels in Psoriatic Arthritis

By

Statin therapy was associated lower CRP levels in psoriatic arthritis treated with statins, possibly indicating decreased systemic inflammation.

No Significant Risk for Atrial Fibrillation, CV Events in PsA Receiving Ustekinumab vs TNF Inhibitors

No Significant Risk for Atrial Fibrillation, CV Events in PsA Receiving Ustekinumab vs TNF Inhibitors

By

The primary and secondary outcomes included incident AF or a composite CV event that included myocardial infarction, stroke, and coronary revascularization.

Ustekinumab and Secukinumab Safe, Efficacious for Psoriatic Arthritis

Ustekinumab and Secukinumab Safe, Efficacious for Psoriatic Arthritis

By

Among a new line of biological and targeted synthetic DMARD, ustekinumab and secukinumab have shown favorable safety and efficacy profiles for psoriasis and arthritis, respectively in patients with psoriatic arthritis.

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

By

Patients with psoriatic arthritis had greater entheseal insertion damage scores compared with patients with ankylosing spondylitis.

Radiographic Changes in PsA: Conventional Synthetic DMARDs vs Anti-TNF Therapy

Radiographic Changes in PsA: Conventional Synthetic DMARDs vs Anti-TNF Therapy

By

Investigators assessed radiographic progression in patients with psoriatic arthritis following transition from conventional synthetic disease-modifying rheumatic drugs to anti-tumor necrosis factor-α therapy.

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

By

Investigators sought to determine the validity of using a simplified scoring tool that assesses 28 joint counts compared with the original 66/68 joint counts in patients with psoriatic arthritis.

PsA Activity During and After Pregnancy Affected by Biologic Therapy

PsA Activity During and After Pregnancy Affected by Biologic Therapy

By

Investigators explore the impact of pregnancy on PsA disease activity, as well as the effect of biologic therapy on PsA disease activity during and following pregnancy.

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

By

Risk for type 2 diabetes, ischemic heart disease, and peripheral vascular disease was elevated among patients with psoriatic arthritis compared with the general population.

Sustained Improvements in PsA With Certolizumab Pegol Monotherapy, DMARD Combination

Sustained Improvements in PsA With Certolizumab Pegol Monotherapy, DMARD Combination

By

Results from the RAPID-PsA study showed that patients with PsA who are treated with certolizumab pegol sustained improvements over the course of 4 years when it is taken as a monotherapy or concomitant with DMARDs.

Incidence, Predictors of Orthopedic Surgery in Psoriatic Arthritis

Incidence, Predictors of Orthopedic Surgery in Psoriatic Arthritis

By

Researchers quantified the incidence of orthopedic procedures in patients with psoriatic arthritis.

Effects of Age, Disease Duration on Bone Erosions in Psoriasis, Psoriatic Arthritis

Effects of Age, Disease Duration on Bone Erosions in Psoriasis, Psoriatic Arthritis

By

Data show that psoriatic arthritis acts as a strong enhancer of age-related catabolic bone damage.

Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis

Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis

By

Rheumatologist-assessed inflammatory back pain (IBP) or the criteria for IBP developed for ankylosing spondylitis might not perform well when determining axial involvement in psoriatic arthritis.

Assessing Disease Activity During, After Pregnancy in Psoriatic Arthritis

Assessing Disease Activity During, After Pregnancy in Psoriatic Arthritis

By

Disease activity was altogether low and stable from preconception to 1 year postpartum among pregnant women with psoriatic arthritis.

Ixekizumab Demonstrates No New Safety Concerns for Treatment of Psoriatic Arthritis

Ixekizumab Demonstrates No New Safety Concerns for Treatment of Psoriatic Arthritis

By

The safety profile of ixekizumab in the treatment of psoriatic arthritis is similar to the safety profile observed with ixekizumab for the treatment of plaque psoriasis.

Sustained Minimal Disease Activity in Psoriatic Arthritis Prevents Progression of Atherosclerosis

Sustained Minimal Disease Activity in Psoriatic Arthritis Prevents Progression of Atherosclerosis

By

Sustained minimal disease activity should be maintained for a prolonged period in order to prevent progression of carotid atherosclerosis and arterial stiffness in patients with PsA.

OMERACT Group Develops Reliable Ultrasound Definition of Enthesitis in PsA, SpA

OMERACT Group Develops Reliable Ultrasound Definition of Enthesitis in PsA, SpA

By

A final reliable ultrasound score and definition of enthesitis in SpA and PsA were produced by the OMERACT group.

Reduced Synovial Inflammation With Secukinumab in Psoriatic Arthritis

Reduced Synovial Inflammation With Secukinumab in Psoriatic Arthritis

By

Treatment with secukinumab over 24 weeks led to a decrease of synovial inflammation and no progression of catabolic and anabolic bone changes in patients with PsA.

Extended Efficacy of Ixekizumab in Psoriatic Arthritis With Prior Inadequate TNFi Response

Extended Efficacy of Ixekizumab in Psoriatic Arthritis With Prior Inadequate TNFi Response

By

The overall safety profile of ixekizumab in psoriatic arthritis remained consistent with that reported in the initial 24-week, double-blind study period.

Efficacy of ABT-122 Maintained in Psoriatic Arthritis, Rheumatoid Arthritis at 36 Weeks

Efficacy of ABT-122 Maintained in Psoriatic Arthritis, Rheumatoid Arthritis at 36 Weeks

By

ABT-122 demonstrated acceptable tolerability and maintenance of efficacy at 36 weeks in patients with RA or PsA receiving background methotrexate.

Minimal Disease Activity Provides Valid Assessment of Adalimumab-Treated Psoriatic Arthritis

Minimal Disease Activity Provides Valid Assessment of Adalimumab-Treated Psoriatic Arthritis

By

Minimal disease activity provided a stable and valid assessment of clinical status over the course of 24 months in patients with psoriatic arthritis.

Few Sonographic Enthesitis Scoring Instruments Validated in Psoriatic Arthritis

Few Sonographic Enthesitis Scoring Instruments Validated in Psoriatic Arthritis

By

Sonographic enthesitis scoring instruments have been developed for spondyloarthritis, but only a few have been validated in psoriatic arthritis.

Prevalence of Psoriatic Arthritis Quantified in Patients With Psoriasis

Prevalence of Psoriatic Arthritis Quantified in Patients With Psoriasis

By

Researchers sought to estimate the occurrence of psoriatic arthritis in patients with psoriasis.

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

By

Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.

Axial Involvement in Psoriatic Arthritis Associated With Poorer Clinical Outcomes, Quality of Life

Axial Involvement in Psoriatic Arthritis Associated With Poorer Clinical Outcomes, Quality of Life

By

Researchers analyzed the characteristics of patients with psoriatic arthritis with and without axial involvement.

Examining the Influence of Disease Manifestations on Quality of Life in Psoriatic Arthritis

Examining the Influence of Disease Manifestations on Quality of Life in Psoriatic Arthritis

By

Health-related quality of life was diminished in psoriatic arthritis at time of diagnosis compared with the general population.

Sign Up for Free e-newsletters